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mechatronic toys for preterm infants at risk
of neurodevelopmental disorders (CARETOY):
a RCT protocol
Giuseppina Sgandurra1, Laura Bartalena2, Giovanni Cioni1,3*, Gorm Greisen4, Anna Herskind4,5,6,
Emanuela Inguaggiato1,7, Jakob Lorentzen6,8, Jens Bo Nielsen5,8, Elisa Sicola1 and the CareToy ConsortiumAbstract
Background: Preterm infants are at risk for neurodevelopmental disorders, including motor, cognitive or behavioural
problems, which may potentially be modified by early intervention. The EU CareToy Project Consortium
(www.caretoy.eu) has developed a new modular system for intensive, individualized, home-based and family-centred
early intervention, managed remotely by rehabilitation staff. A randomised controlled trial (RCT) has been designed to
evaluate the efficacy of CareToy training in a first sample of low-risk preterm infants.
Methods/Design: The trial, randomised, multi-center, evaluator-blinded, parallel group controlled, is designed
according to CONSORT Statement. Eligible subjects are infants born preterm without major complications, aged 3-9
months of corrected age with specific gross-motor abilities defined by Ages & Stages Questionnaire scores. Recruited
infants, whose parents will sign a written informed consent for participation, will be randomized in CareToy training
and control groups at baseline (T0). CareToy group will perform four weeks of personalized activities with the
CareToy system, customized by the rehabilitation staff. The control group will continue standard care. Infant
Motor Profile Scale is the primary outcome measure and a total sample size of 40 infants has been established.
Bayley-Cognitive subscale, Alberta Infants Motor Scale and Teller Acuity Cards are secondary outcome measures. All
measurements will be performed at T0 and at the end of training/control period (T1). For ethical reasons, after this
first phase infants enrolled in the control group will perform the CareToy training, while the training group will
continue standard care. At the end of open phase (T2) all infants will be assessed as at T1. Further assessment will
be performed at 18 months corrected age (T3) to evaluate the long-term effects on neurodevelopmental outcome.
Caregivers and rehabilitation staff will not be blinded whereas all the clinical assessments will be performed,
videotaped and scored by blind assessors. The trial is ongoing and it is expected to be completed by April 2015.
Discussion: This paper describes RCT methodology to evaluate CareToy as a new tool for early intervention in
preterm infants, first contribution to test this new type of system. It presents background, hypotheses, outcome
measures and trial methodology.
Trial registration: ClinicalTrials.gov: NCT01990183. EU grant ICT-2011.5.1-287932.
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The incidence of preterm births has increased and sur-
vival rates in very preterm infants have improved over
the past two decades [1,2]. However, a significant num-
ber of these infants, especially if born with a very low
birth weight (VLBW), show a developmental disorder.
Follow-up studies indicate that up to 15% of infants are
diagnosed with cerebral palsy and about 50% show cog-
nitive, motor, or behavioural problems in childhood
[3-5], resulting in a lower high school graduation rate
compared with infants born at term with normal birth
weight [6].
Early developmental interventions have been used in
the clinical setting with the aim of improving the overall
outcome for preterm infants [7]. Early Intervention (EI)
means intervening as soon as possible to tackle prob-
lems that have already emerged due to perinatal or
congenital brain disorders. It is carried out in a crit-
ical period of development (i.e. a time window during
which specific functions develop very rapidly), when
initial signs of atypical development are present but
before they become overt. The target of EI training is
to strengthen brain plasticity, higher in the first years
of life, and to allow a better functional outcome. Ac-
cording to the neuroscience evidences, the activity-
dependent neural plasticity is able to mould the neural
development mainly during the critical periods, as indi-
cated by several examples especially for motor and visual
systems, both in animal models and in infants with brain
lesion [8-12].
Based on our current neurobiological understanding,
EI programs have to be implemented very early in life
and should be intensive, repetitive, incrementally chal-
lenging, and individualized. They should include also
goal-directed components and exercises where meaning-
ful goals are provided, to give opportunities for problem
solving and to indirectly drive the movements required
to successfully meet task demands [13,14]. The thera-
peutic approach should also involve repeated practice of
tasks, which the infant wants to do [15]. There is also
accumulating evidence of the importance of an enriched
environment (EE) on infant's neurodevelopment [16-20].
Home EE should be organized to encourage the infant
to perform specific tasks, tailored on the developmental
needs of the individual infant, in an environment where
the parent is actively and positively engaged with the
child, to facilitate and promote learning. The home en-
vironment should include safe toys appropriate to the
infant's ability level but posing a learning challenge
and family interactions. In this context, as proposed by
Morgan et al. [21], EE intervention could be defined as a
set of modifications aimed to enrich motor, cognitive,
sensory, or social aspects of the infant’s environment
with the purpose of promoting learning.Systematic and Cochrane Reviews [5,22,23] indicate an
evidence of the positive effects of EI, mainly based on
parents involvement, on the development of cognitive
and motor functions in preterm infants. However, the
identification of the most effective intervention strategies
is difficult and more RCT, including control groups, with
well defined content, focus, duration and intensity are
deeply needed.
Moreover, providing infants at high risk of neurodeve-
lopmental disorders by an EI personalized and with sig-
nificant intensity and duration would impose high costs
for the Health Care System. Even in western countries
resources are unlikely to be sufficient to cover all needs.
Moreover, some families have difficulties, for different
reasons, to reach health care services. Biotechnologies,
tele-rehabilitation and eHealth could represent a promis-
ing approach to provide home EI programs for a large
number of infants at a relatively low cost.
On this background, the CareToy Project (www.
caretoy.eu, Trial Registration: NCT01990183) has aimed
to develop a new technological smart modular system as
a tele-rehabilitation tool for EI in infants at risk for neu-
rodevelopmental disorder. The CareToy system for EI,
called CareToy Home is composed by four modules:
1) gym module made of i) a kit of sensorized toys with dif-
ferent shape and size, ii) two interactive walls (feedback
wall with embedded sounds and lights), iii) a belt wall with
a sensorized pillow, iv) an arch with lights, v) 4 cameras;
2) vision module (screen wall), equipped with a large
monitor; 3) mat module with a sensorized mat and three
wearable sensors (two bracelets and chest strap) [24,25]
and 4) tele-rehabilitation module that allows the commu-
nication between CareToy system and clinical centre
(Figure 1A).
The software includes principles, procedures and com-
puter algorithms for data acquisition, processing and
sensory integration from various sensors. Signal process-
ing is performed in two different modes: i) real-time
processing that provides information relevant for gener-
ating immediate feedback to the infant based on his/her
activity and ii) post-processing of data that allows more
detailed off-line analysis of the infant’s behaviour.
CareToy allows an intensive, individualized, home-
based and family-centred intervention, managed re-
motely by trained clinical staff. The rehabilitative staff
may use the modular organization and the possibility of
activating single parts of the system (e.g. there are many
lights in the wall but they are hidden and they can be
variously activated associated or not with sounds/music)
automatically and/or in relation to the actions of the in-
fant (e.g. only if the infant rolls or grasps) to tailor the
training to the individual needs of the infant. The infant
may in this way be promoted to actively perform specific
goal-directed activities (e.g. for postural control, reaching,
Figure 1 CareToy for Home and CareToy for Clinics. A, 1) Set up of CareToy for Home (CareToy H). It is delivered at home and used to
promote infants’ motor and perceptual development, through individualized goal directed activities (rehabilitation packages of CareToy training).
2) Kit of sensorized toys. 3) The four modules of CareToy H (Gym, Vision, Mat and Tele-rehabilitation). B, 1) CareToy for Clinics (CareToy C), installed
at the rehabilitation centres. 2) Reconstruction of the gaze of an infant during the observation tasks.
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garding the performance of the infant is obtained by
video and sensors in toys and mattresses. They provide
quantitative information about grasp shape and force,
orientation and displacement in space of toys and pos-
tural changes of the infant. Acquired data are automat-
ically uploaded to a clinical database server through the
tele-rehabilitation module. This also allows the rehabili-
tation staff to manage the training remotely, plan new
individualized exercises, assess the validity of the exer-
cises and create and update new exercises. The CareToy
training in this way guarantees a highly variable and indi-
vidualized approach, tailored on the specific needs of the
infant and on the achievement of specific goals.
In the context of the CareToy project a platform for
the quantitative evaluation of visual abilities has been
also developed. This is named CareToy for Clinics and it
is a highly advanced system, which is installed in the
clinical centres and used only by expert rehabilitation
staff. It consists of an eye tracking system (Smart Eye
Pro system) equipped with 6 external infrared cameras
running at 60 Hertz placed in an integrated mechanical
structure with 5 screens and 5 loudspeakers (placed one
in the centre, two on the right side at 30° and 60° and
two on the left side, also at 30° and 60°) (Figure 1B).
To test the effects of the CareToy training on infant’s
neurodevelopment we propose a randomised controlled
trial (RCT) in a population of low risk preterm infants.The trial fulfils the criteria set out in the Consolidated
Standards of Reporting Trials (CONSORT) Statement
for Randomised Trials of non-pharmacologic treatment
guidelines [26,27].
Methods/Design
The following hypotheses will be tested in the RCT:
 CareToy training may improve the
neurodevelopmental (e.g. motor, perceptual and
cognitive) outcome in preterm infants;
 CareToy training may help caregiver, whose role is
essential for EI, in assisting skill development in their
child by adapting the physical and play environment
of the system;
 CareToy system, with the characteristics pointed out
above, designed and carried out in the CareToy project
with also tele-rehabilitation and ICT strategies, could
represent a novel home-based, rehabilitation setting for
infants born preterm or at risk for neurodevelopmental
disorders, for their families and for health system.
These experimental hypotheses will address the following
specific aims:
– To provide first evidences that CareToy,
compared to standard care, is useful to promote
neurodevelopment in low risk preterm infants.
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infant interaction during play activities.
– To provide evidence that the CareToy system is a
suitable tool for an enriched and playful EI setting at
home.
If these aims will be achieved in low risk
preterm infants, CareToy may be proposed
as a new rehabilitation tool for infants at
high risk of developing neurodevelopmental
disorders.
Study design
A multicenter, evaluator-blinded, parallel group RCT
will be carried out to compare the effects of the CareToy
training to standard care in preterm infants.
The two clinical centres involved in the study are the
IRCCS Fondazione Stella Maris, Department of Develop-
mental Neuroscience, in Pisa (Italy), in collaboration
with Neonatal Intensive Care Unit, Pisa University
Hospital “Santa Chiara” and in Copenhagen (Denmark) the
Helene Elsass Center, in collaboration with the University
of Copenhagen (Depts. of Neuroscience and Pharma-
cology and Neonatology, Rigshospitalet). Clinical assess-
ment will be performed at baseline (T0, in the week
preceding the CareToy intervention/standard care) and
in the week after the end of CareToy training/standard
care (T1, primary endpoint). For ethical issues, after
T1, the infants who start with standard care will have
the opportunity to receive the CareToy training, while
the infants that have already performed CareToy trai-
ning will continue standard care. At the end of this
open phase (T2), all the infants will be assessed as at
T1. Moreover, a further assessment will be performed
at 18 months of corrected age (T3) to evaluate the
long-term effects on neurodevelopmental outcome. The
experimental design and the timeline are described in
detail in Figure 2. A pilot study has been performed in
order to assess the feasibility of the CareToy training
and to tune and set-up the CareToy system and the re-
habilitation packages.
Study sample and recruitment
The study population will consist of preterm infants
recruited at the local Neonatology Units (“Santa Chiara”
University Hospital in Pisa and Rigshospitalet in
Copenhagen). Eligible infants will be identified according
to strict inclusion and exclusion criteria (see below) by
the Neonatology teams before the discharge. They will
inform the caregivers about the study and, if inter-
ested, the information letter and the informative flyer
about the project will be given. Recruitment should
take place after discharge until 9 months of corrected
age. If the parents accept to participate they will pro-
vide their written informed consent for the infant totake part of the study. Extensive perinatal data will be
collected from medical records and the infants will be
evaluated on the basis of a standard neurological examin-
ation (Hammersmith Neurological Examination, HINE
[28,29] and by Prechtl’s General Movements Assessment,
GMA [30,31]).
The clinical trial has been approved by the Ethics
Committee of Pisa University Hospital (Italy), Tuscan
Region Pediatric Ethics Committee (Italy) and to Ethics
Committee of Region Hovedstaden (Denmark). More-
over, the Italian Ministry of Health has approved the
trial considering that the CareToy is configured as a
medical device without a CE mark.
This study will include preterm infants that met the
following criteria:
Inclusion Criteria:
 gestational age ≥28 + 0 weeks and 32 + 6 weeks
 corrected age at baseline: between 3 and 9 months;
 achievement of predefined cut off scores in gross
motor ability derived from Ages & Stages
Questionnaire® Third Edition (ASQ-3), in relation to
corrected age [32].
In detail:
– 4 months form (from 3 months to 4 months
30 days) score ≥10;
– 6 months form (from 5 months to 6 months
30 days) score ≥5 - <50;
– 8 months form (from 7 months to 8 months
30 days) ≥10 - <30
Exclusion Criteria:
 infants with gestational age <28 weeks or ≥33 weeks
 infants small for gestational age (i.e. weight below
the 10th)
 presence of brain damage i.e. brain malformation,
intra-ventricular haemorrhage (IVH) >1; any degree
of periventricular leukomalacia (PVL)
 known epilepsy or other form of seizure
 severe sensory deficits (blindness, deafness)
 other severe non neurological malformations
 participation in other experimental studies having
rehabilitation aims
Sample size
According to CONSORT guidelines [26,27] the sample
size estimates were based on projected treatment effect
on the primary outcome measure, the Infant Motor Pro-
file (IMP [33,34], see below). A sample of 36 infants is
required to detect a clinically relevant change of 7.5
points in the total IMP score (SD = 8.2) at significance
Figure 2 Flow-chart of CareToy study according to CONSORT guidelines. NICU: Neonatal Intensive Care Unit; GA: Gestational Age; IMP:
Infant Motor Profile; AIMS: Alberta Infant More Scale; BSID-III Cog: Bayley Scales of Infant Development III- Cognitive Subscale; Teller: Teller Acuity
Cards; CTC: CareToy for Clinics; ASQ-3: Ages & Stages Questionnaire Third Edition; S-E BSDI-III: Social-Emotional Scale of Bayley III; PSI: Parenting
Stress Index; CA: Corrected Age.
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possible drop-outs a minimum of 40 infants will be
recruited. Twins will always be assigned to the same
group, in order to facilitate the parents in managing the
CareToy system for their infants.
Randomisation
After enrolment, infants will be randomly allocated to
the intervention (CareToy training) or control group
using a computer generated set of random pair 1:1 allo-
cation (CareToy training – standard care or standardcare – CareToy training). These random sets will be
sealed in numbered envelopes.
Blinding
Caregivers, therapists and study personnel who follow
the infants during the trial will not be blinded about
the allocation group. Outcome measures (Infant Motor
Profile, IMP; Alberta Infant Motor Scale, AIMS; Bayley
Scales of Infant Development III Edition, BSID-III) will be
performed, videotaped and scored by assessors who are
blinded to group allocation.
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CareToy training
On the base of each infant’s developmental needs, the
rehabilitation staff (e.g. child neurologists and paediatric
physical therapists) will plan a series of individualized
goal-directed activities (rehabilitation packages) mainly
focused on postural control, reaching, grasping, manipu-
lation, visual attention and orientation in supine, prone
and/or sitting position. According to the planned activ-
ities, the CareToy system will be personalized and deliv-
ered at the home of the infant. The CareToy training will
be used daily for 4 weeks (28 days). Each daily training lasts
about 30-45 minutes and consists of various activities of 2-
10 minutes duration performed during the day when
the infant is in active state and compliant.
Daily training will be remotely monitored by the re-
habilitation staff, who may modify the rehabilitation
packages according to infant’s developmental needs and
progress. Caregivers will fill out a questionnaire at the
end of each training session to record acceptance and
compliance to the activities by the infant. The drop-out
criterion for each daily session is if the infant completes
less than 51% of the planned scenarios.
Caregivers will be trained in playing with their infant
through the CareToy system during the first training
week by the rehabilitation staff. In the following 3 weeks
of training, support and advice will be given, even on site
if necessary.
Standard care
Standard care refers to the current care advice, which is
similar in Pisa and Copenhagen, in the management of
preterm infants in the first months of life.
Outcome measures
During the study period infants will be assessed at base-
line and then at three different time points (Figure 2).
The infants' assessment will be performed in each clin-
ical centre, by blinded assessors, who are trained in the
use of the outcome scales. To guarantee a high level
of evaluation and score agreement, during the months
preceding the beginning of the study, the assessors had
worked together sharing assessments and scores.
The assessment of motor development has been chosen
as primary outcome measure using IMP. The following
secondary outcomes have been chosen: AIMS, BSID-III
Cognitive subscale and Teller Acuity Cards®. Each assess-
ment can be done in two consecutive days to ensure
greater compliance by the infant.
Primary outcome measure
Infant Motor Profile (IMP)
It is a new, video-based and qualitative assessment of
motor behaviour in infancy, applicable in preterm and atterm infants aged 3 to 18 months [33]. It consists of 80
items addressed to explore the child's motor abilities
and to evaluate motor behaviour in five domains: i) vari-
ation, ii) variability (ability to select motor strategies),
iii) movement fluency, iv) movement symmetry and
v) motor performance.
IMP consists of spontaneously and elicited motor be-
haviour recording while the infants are in supine, prone,
sitting, standing, walking (depending on infants' age and
functional capacity), reaching, grasping, and manipula-
tion of objects in supine and in supported sitting posi-
tions. The assessment lasts approximately 15 minutes.
The total IMP score is constituted by the mean of the
five domain scores. It is scored off-line on the basis of
the video recordings.
This tool is intended to detect and quantify changes
after intervention and it is reported as having a satisfac-
tory intra and inter-observer reliability and a good score
reliability. In particular, it has been demonstrated that the
inter-observer reliability of the total IMP score yielded an
ICC of 0.94 (95% CI 0.87–0.97), and the reliability of scor-
ing the IMP domains moderate to good, with ICCs ran-
ging from 0.69 to 0.99. Moreover a strong correlation
between IMP performance domain score and AIMS has
been found [33,34]. This evaluation will be carried out at
all four time-points (T0-T3), but only the change from T0
to T1 will be used as the primary outcome.
Secondary outcome measures
Alberta Infant Motor Scale (AIMS)
This standardized scale examines delayed and abnormal
motor development in infants overtime and it is a tool
for assessment from term until 18 months of age [36].
AIMS assesses infant movement in four positions: prone,
supine, sitting and standing, requiring about 20-30 mi-
nutes of administration time. The scale is quick to ad-
minister with limited handling and focuses on achievement
of motor milestones, quality of posture and movement
outcomes [37].
AIMS has been shown to be sufficiently sensitive to
differentiate the motor development of preterm infants
from that of full term infants. This evaluation will be
carried out at all four time-points (T0-T3).
BSID-III-Cognitive subscale
This scale is sensitive in detecting differences between a
normative sample and children at risk for delayed devel-
opment, such as premature infants. It has normative
value referenced assessments, with means of 100 and
Standard Deviation (SD) of 15 points. Children whose
scores are 2 SDs below the normative value in a domain
are considered as having a significant delay in that as-
pect of development. Bayley III is appropriate for admin-
istration to children between the ages of 1 month and
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of 16 days). The Bayley III revision includes Cognitive,
Language, Motor, Social-Emotional, and Adaptive Be-
haviour scales. Items on the cognitive subscale assess
sensor-motor development, exploration, manipulation,
object relatedness, concept formation, problem-solving
and memory [38]. This evaluation will be carried out at
T0 and at T3.
Teller acuity cards®
Teller Acuity Cards II is a test used to evaluate visual
acuity in infants and children. It is based on judgement
of the infant attention to a series of cards showing
stripes of different widths. This tool allows rapid assess-
ment of resolution (grating) visual acuity in infants and
young children, and other populations where verbal re-
sponse to recognition (letter) visual acuity charts is diffi-
cult or impossible [39-41]. It evaluates development of
visual acuity and it has been used in several studies for
diagnostic purposes and to measure the results of early
intervention [18,42,43]. This evaluation will be carried
out at all four time points (T0-T3). Visual Acuity assess-
ment will complemented by quantitative evaluation of
visual fixation and visual following, by means of an eye-
tracker (CareToy for Clinics).
Questionnaires
Ages & stages questionnaire® third edition (ASQ-3)
It has been developed as a screening tool for develop-
mental delay in infants in numerous paediatric popula-
tions with reported easy administration, short completion
time, easy interpretation, sensitivity, measure of true posi-
tives, and specificity, measure of true negatives, varying,
with most studies reporting higher accuracy in at risk pop-
ulations [32,44-46].
The questionnaire covers from 1 to 66 months of age.
The parents answer 30 questions that assess 5 domains
of development, including communication, gross motor,
fine motor, problem-solving, and adaptive skills. This
self-administered assessment can be completed in 10 to
20 minutes and scored in 1 to 5 minutes.
The questionnaire will be given to parents after enrol-
ment in order to define the most appropriate starting
time for each infant (see inclusion criteria), Moreover, it
will be given to the parents during all assessments in
order to explore infant development from the parental
point of view.
Social-emotional scale of BSID-III
It is a screening tool to measure social-emotional mile-
stones in young children aged 0-42 months for early
identification of social-emotional deficits and planning
of the most successful interventions. It is filled out by
the parents and contains 35 items, rated using a 5-pointscale and ordered developmentally, according to age at
which each item is typically mastered [47]. This ques-
tionnaire will be carried out at all time points (T0-T3).
Parenting Stress Index (PSI)
It is a self-report questionnaire designed to identify spe-
cific parental, child and situational characteristics most
commonly associated with dysfunctional parenting [48].
Currently, the PSI is mostly used as a screening instru-
ment for the early identification of parent-child systems,
which are under stress and at risk of developing dysfunc-
tional parenting behaviour. The validity of the PSI has
been established in numerous studies on children with
developmental problems, behaviour problems, disabil-
ities and illnesses, as well as studies of at risk families
and cross-cultural studies [49]. The questionnaire will be
carried out at all time points (T0-T3).
Analyses
Clinical Data will be managed and analysed using the
Statistical Package for Social Sciences (SPSS). Descrip-
tive statistics (means, standard deviation) will be calcu-
lated to summarise the data set for both groups and to
identify potential baseline differences between the groups;
p values will be used to indicate the strength of the evi-
dence, and the Bonferroni correction for multiple assess-
ments will be performed. The primary level of analysis will
be the assessment of the effects of CareToy training at the
primary endpoint (T1) in the primary and then in the sec-
ondary outcome measures. In the second level analysis we
will provide multivariate statistics in order to take into
account effect modifiers such as basal level of motor devel-
opment, family compliance and time of training.
Discussion
The paper presents the background and the design for a
RCT comparing a new intervention, CareToy Home,
with the standard care for infants at low risk for neuro-
developmental disorders.
The study is the first to test this new type of treatment as
a new tool for an intensive, individualized, home-based
and family-centred intervention, managed remotely by
clinical staff. The present research aims to assess the feasi-
bility of the system and determine its effect on the neuro-
development of a group of preterm infants at low risk for
neurodevelopmental disorders. If successful, a future
aim is to apply the system in further studies involving
infants at higher risk for brain lesion or genetic disorders.
The CareToy Home system represents a challenging and
innovative tool in the field of infant rehabilitation.
This trial will explore the applicability of a new fron-
tier of tele-medicine in infants. This opens the possibility
of managing early intervention in infants at home from
the clinical centre, expanding the access of infants to EI.
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CONSORT guidelines [26,27] will allow us to evaluate
the effects of CareToy training on neuro-developmental
outcome in a first sample of at low risk preterm infants.
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